Literature DB >> 22755690

On using 3D γ-analysis for IMRT and VMAT pretreatment plan QA.

Chuan Wu1, Kelly E Hosier, Kristen E Beck, Marlyn B Radevic, Joerg Lehmann, Hao H Zhang, Aaron Kroner, Sharon C Dutton, Seth A Rosenthal, Jonathan K Bareng, Mark D Logsdon, David R Asche.   

Abstract

PURPOSE: To investigate using 3D γ analysis for IMRT and VMAT QA.
METHODS: We explored and studied 3D γ-analysis by comparing TPS computed and EPID back-projection reconstructed doses in patient's CT images. Two 3D γ quantities, γ(PTV) and γ(10), were proposed and studied for evaluating the QA results, and compared to 2D γ (MapCheck composite: γ(MC)).
RESULTS: It was found that when 3%(global)/3 mm criteria was used, all IMRT and 90% of VMAT plans passed QA with a γ pass rate ≥90%. A significant statistical correlation was observed between 3D and 2D γ-analysis results for IMRT QA if γ(10) and γ(MC) are concerned, but no significant relation is found between γ(PTV) and γ(MC).
CONCLUSIONS: 3D γ analysis based on EPID dose back-projection may provide a feasible tool for IMRT and VMAT pretreatment plan QA.
© 2012 American Association of Physicists in Medicine.

Entities:  

Mesh:

Year:  2012        PMID: 22755690     DOI: 10.1118/1.4711755

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  12 in total

1.  Comparison of 2D and 3D gamma analyses.

Authors:  Kiley B Pulliam; Jessie Y Huang; Rebecca M Howell; David Followill; Ryan Bosca; Jennifer O'Daniel; Stephen F Kry
Journal:  Med Phys       Date:  2014-02       Impact factor: 4.071

2.  Can clinically relevant dose errors in patient anatomy be detected by gamma passing rate or modulation complexity score in volumetric-modulated arc therapy for intracranial tumors?

Authors:  Shingo Ohira; Yoshihiro Ueda; Masaru Isono; Akira Masaoka; Misaki Hashimoto; Masayoshi Miyazaki; Masaaki Takashina; Masahiko Koizumi; Teruki Teshima
Journal:  J Radiat Res       Date:  2017-09-01       Impact factor: 2.724

3.  Clinical implementation and error sensitivity of a 3D quality assurance protocol for prostate and thoracic IMRT.

Authors:  Gueorgui Gueorguiev; Christopher Cotter; Julie Catherine Turcotte; Bruce Crawford; Gregory Sharp; Mufeed Mah'D
Journal:  J Appl Clin Med Phys       Date:  2015-09-08       Impact factor: 2.102

4.  Individual volume-based 3D gamma indices for pretreatment VMAT QA.

Authors:  Jinling Yi; Ce Han; Xiaomin Zheng; Yongqiang Zhou; Zhenxiang Deng; Congying Xie; Xiance Jin; Fu Jin
Journal:  J Appl Clin Med Phys       Date:  2017-03-20       Impact factor: 2.102

Review 5.  A six-year review of more than 13,000 patient-specific IMRT QA results from 13 different treatment sites.

Authors:  Kiley B Pulliam; David Followill; Laurence Court; Lei Dong; Michael Gillin; Karl Prado; Stephen F Kry
Journal:  J Appl Clin Med Phys       Date:  2014-09-08       Impact factor: 2.102

6.  Multidimensional correlation among plan complexity, quality and deliverability parameters for volumetric-modulated arc therapy using canonical correlation analysis.

Authors:  Lanxiao Shen; Shan Chen; Xiaoyang Zhu; Ce Han; Xiaomin Zheng; Zhenxiang Deng; Yongqiang Zhou; Changfei Gong; Congying Xie; Xiance Jin
Journal:  J Radiat Res       Date:  2018-03-01       Impact factor: 2.724

7.  Comparison of 3D and 2D gamma passing rate criteria for detection sensitivity to IMRT delivery errors.

Authors:  Dandan Zhang; Bin Wang; Guangshun Zhang; Charlie Ma; Xiaowu Deng
Journal:  J Appl Clin Med Phys       Date:  2018-06-15       Impact factor: 2.102

8.  Composite QA for intensity-modulated radiation therapy using individual volume-based 3D gamma indices.

Authors:  Ce Han; Wenliang Yu; Xiaomin Zheng; Yongqiang Zhou; Changfei Gong; Congying Xie; Xiance Jin
Journal:  J Radiat Res       Date:  2018-09-01       Impact factor: 2.724

9.  Clinical implementation of Dosimetry Check™ for TomoTherapy® delivery quality assurance.

Authors:  Eunah Chung; Dongyeol Kwon; Taeyang Park; Hyeri Kang; Yoonsun Chung
Journal:  J Appl Clin Med Phys       Date:  2018-10-24       Impact factor: 2.102

10.  To propose adding index of achievement (IOA) to IMRT QA process.

Authors:  Dong-Su Kim; Siyong Kim; Seong-Hee Kang; Tae-Ho Kim; So-Hyun Park; Kyeong-Hyeon Kim; Min-Seok Cho; Dong-Seok Shin; Yu-Yun Noh; Jin-Beom Chung; Tae Suk Suh
Journal:  Radiat Oncol       Date:  2018-06-15       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.